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Various 4- and 8- aminoquinoline derivatives having different substituents in the side chain and in 
the nucleus have been discussed in respect of their antimalarial activity, toxicity and tolerance dosages. The 
effect of the incorporation of different moieties e.g. piperazine, piperidine and quinoline itself has also been 
highlighted. Certain quinoline quinones and benzoquinones as effective antimalarial agents have also been 
described. 
Since 1880, when Alphonse Laverw established 
plasmodium as the causative agent for malaria, 
man has searched for a remedy for the disease from 
am ng the natural products. The chinese drug 
cH30E@) 
Fe g rifuga (I) was one such product isolated from NH-CH--(CH~)~-N ~ ' 2 ~ 5  
dichroa febrifuga. Pelletier and Caventon isolated I CH3 
'C2H5 
quinine and cinchonine alkaloids from cinchona 
bark. After years df reliance on cinchona bark and 
quinine, the development of synthetic antimala- 
rial, was initiated by German workers, prompted 
by enemy control of quinine supplies in world war I. 
Their starting point was methylene blut (11) which 
had been shown to possess some antimalarial 
activity. 
Although it is a potent antimalarial, $et its use 
is not advised because the margin of safety'betwea 
therapeutic and toxic dose is too small. Subse- 
quently, in the antimalarial programme, for synthe- 
sising new diugs, carried out under the Committee 
on Medical Research, it was found that 8-(6'-diethyl- 
aminohexy1amino)-6-methoxy lepidine had an 
extremely high antimalaiial activity in avian malaria 
tests and the introduction of a 4-methyl group (IV) 
increased the quinine equivalent by about ten folds 
when tested against Lophurae malaria in duckl. 
(R = Different Dialkylaminostlkylamino side chains.) 
Structural variations in the methylene blue indie The antimalarial activity together with a toxicity 
cated that a dialkylaminoalkylamino side chaip much lower than that of the related quinolines 
was essential for activity and the researches culmi- promoted further work in this field. Campbell2 
nated in the development of the first synthetic et al. synthtsised the products of V (R=N&) 
antimalarial drug Plasmochin (Pamaquin) 111. with different 4-substituted alkyles, aldehydes, 
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alcohols and esters. But as the products had no 
appreciable antimalarial activity, no further effcrts 
were made to prepare other drugs in this series. 
The sea~ch for the pamaquine analogue led to 
the synthesis3 of dphydroxy ethoxy-b-diethy- 
laminoalkylaminoquinoli~ es, which are less toxic 
to the host and yet these retain their therapeutic 
activity. Other such analogue was 6-methoxy-8- 
(pseudohelio-tridylamino) quinoline. 2HCI, 
which showed slight antimalarial activity*. 
Barctt6 et al synthesised the pipe~azine deriva- 
tives of 8-aminoquinoline. Many of the title com- 
pounds with terminal nitrogen atoms have high 
antimalarial activity. 
It was observed that the amino-group instead of 
substituted amino-in the alkylamino side chain of 
the pamaquine, provided the superior drug prima- 
quine (V), whi'ch is particularly effective in pre- 
venting relapses and is curative against vivax 
These derivatives were curative in rhesus mon- 
key against P. cynomolgi screen. 
Until the early 1940s, the value of 4-amino- 
quinolines as antimalarial agents was not fully 
recognised, although they had been developed 
some fen years earlier in Germany. Resochin, 
later termed chloroquine (VII, R= H), was origi- 
nally rejected as being too toxic and the attention 
was therefore turned towards sontoquine (VII, 
R = CH,). This drug could be given limited clinical 
trials in Gelmany and by the French in North 
Africa, where supplies fell into American hands 
with the captute of Tunis. 
malaria. ( V I I )  
NH CH-(CH2I3- NH2 
I Thus, interest was again aroused .in the 4-amino- (3"' qainolines and this resulted in the establishment of [ v )  chloroquine as oce of the most effective drugs in 
antimalarial therapys. 
In view of such an observatien; synthesis of 2- 
benzoyl and 2-benzoylthio analogues of (V) was 
undertakene. Thioanalogues of primaquine (VI) 
have also been synthesised?. 
In the hope of achieving some positive results 
with a change in alkylamino-sidechain of chloro- 
quine, Robert synthesised and patented 7-chloro- 
4-[1-methyl-4-(1-pyr~olidyl) butylaminol-quinoline 
and its quaternary ammonium salt as valuable 
antimalarial agent9 . 
Tests with hydroxychloroquine on ducks injec- 
ted with P. lophurae showed that it was 5 times as 
effective as quinacline at 20 mg/kg. It has also less 
toxicity as compared to other 4-aminoquinolines10. 
The incorporation of the piperazine in the alky 
lamino-side chain of chloroquine resulted in the syn- 
thesis of useful antimalarial agents, 1-[2- (7-chloro- 
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4 - quinolyl) aminopropyl] -4-( 2-piperidinoethyl) amino) quinoline and 7-chloro-4-(3-hydroxy-quinu- 
piperazine (VIII) possessed antimalarial activity". clidinyl-2-methyleneamino) quinoline were cura- 
tivel6. 
FH3 A 
NH-CH-CH2- N uNTA-* 
Chloroquine derivatives with unsaeuration in the 
diamine side chain in the form of acetylenic an.d cis 
A z CH2- CH2 
C1 and trans ethylenic bonds were prepared and their 
Z = piperidino antimalarial activity was compared with Chloro- 
quine. It was observed that some were more potent 
( ~ 1 x 1  l and less toxic than chlor oquinel'. 
With a view to synthesise camoquin. analogue with 
Further modification in (VIII) with the inclusioc quaternary side chain, Natrajan et all8 have 
of substituted phenyl ringT2 or differen.t quinoline prepared 4-[3-(a, a-dihydroxy-methylaminomethyl) 
d&i&tives13 instead of piperidino yielded products -4'-hydroxyphenyl-amino]-7-chloroquinoline (X), 
of appreciably high antimalarial activity. which showed antimalarial activity against P. bergbei in mice at a minimum effective dose of 10 
A slight variationincamoquine, by cyclising the 
two ethyl groups, resulted in amopyraquine (IX) 
which was less toxic than chloroquine and useful 
particularly when injected intramuscularly. It has 
0 
~ 0 : H 2 0 H  
optimum antimalarial activity and low toxicityl4. cI F\ cH2oH 
N"2 
( X I  
Elslager et all9 prepared a series of 4-[(7-chloro 
4-quinolyl)amino] -a-[(diethylamino)-O-cresolesters] 
and amide derivatives. Most of the compounds 
exhibited noteworthy activity and protected mice 
against P. berghei for 2-4 weeks at 400 mg/kg. 
The significant role of the alkylamino-side chein 
with various alterations resulting in the useful 
drugs encouraged other workers1' to ~~nthesise Pamaquin was known to prevent the incidence 
the 4-amin0quinolines with quaternalY of malarial relapses, which could not adequately be 
side chains. One of these com~ounds, 7-chloro-4- do, by 4-aminoquinolines and thus interest was 
(3-amino-% 2-dimeth~1~ro~~1amin0) quinoline9 focussed once more on 8-aminoquinolines with a 
was found active when tested on mice infected with vie, to decreasing the toxicity and increasing the 
a lethal dose of P. berghei. effectiveness of pamaquin. Subsequently pentaquine 
and p~imaquine were found to be the least toxic and 
most effective 8-aminoquinolines. Other modifica- 
Quinoline compounds containing quinuclidine tions in pamaquin were made by additional sub- 
ring in the side chain were also prepared and tested stitution at variouspositions. 4-(4'-Chlorophenoxy)- 
for their antimalarial activity against P.bergheiin 6-methoxy-8-nitro quinoline and 8-(5-amino-l- 
mice. ~-Chloro-4-(3-oxoqui1,uclidinyl-2-methylene methyl penty1amino)-6-methoxy lepidine diphos- 
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phate were synthesised and evaluated for their 
antimalarial activity. Both of these were superior 
to p~imaquine with no toxicity at 640 mg/kg and 
the latter at  1 mg/kg was curative against P. 
eynomolgi in the rhesus monkey20, This obstrva- 
tion prompted the other workers21 to bring out 
modified primaquine with alterations at  4-and 8- 
positions. The compounds (XI) thus prepared wele 
not toxic at 640 mg/kg and the most active com- 
pound was (XIa). In the monkey antimalarial 
screen (XIa3 and (XIb) produced radibal cure. 
Andrew24 et a1 prepared and evaluated many of 
2-benzoyl-4-quinoline methanols and observed 
that these were generally mole potent antimalarials . 
and less phototoxic than the corresponding 2- 
phenyl analogues. 
Series of 2-quinolinemethanols with Cl-substi- 
tution at various positions in the quinoline nucleus 
were synthesised. One such compound, a-di-n- 
butyl-aminomethyl-4-(4-chlorophenyl) 6, 8- 
dichloro-2-quinolinemethanol-HCI was curative 
against P. berghei in mice. It extended the mean 
survival time by 6.3 days at 640 mg/kgz5. 
Mefloquine, a 4-quinolinemethanol containing 
I 
NH-CH-(CH 13- NH2 trifluoromethyl group has been recently reported to 
I be most potent antimalarialz6. 
CH3 ar X =F,  citrate 
- 
Brassi27, et  a1 observed the antimalarial acti- 
vity of natural, racemic and synthetic dihydroqui- 
nine, dihydro quinidine and their various racemic 
Various fluorine containing a-dialkylamino- analogues in mice infected with P. berghei. It was 
methyl-2-phenyl-4-quinoline methanols were pre- found that (,t)-dih~aoquinine hemisulfate and 
pared for evaluation against P. berghei. It was its optical antipodes were as active as quinine. HCI 
observed that the F-compounds were more potent at  200 mg/kg (minimum effective oral dose), whereas 
-, - . 
than the corresponding C1-derivatives. One of these dihyd~oquinidine-hemisulfate, 6'-demethoxy-~ 
compounds, a -(dibut~1amin0meth~1)-2-(4-ch10- chlorodihydroquinid& dihydrochloride were 4 
rophenyl)-7-trifluoromethyl-4-quinolinemethanol, 
(X1I)was curative in mice22. times more active at  minimum effective oral dose 
/ C L H ~  
A group of workers switched over to the synthesis 
of quinolinequinones. 7-Alkyl-6-hydroxy-$8-quino- 
line quinones (XIIIa) and 6-Alkyl-7-hydroxy-5, 
0 
2, 8-Bis-(trifluoromethy1)- a -(2-piperidyl)-4-quino: ( XI11 a 1 
line methanol illso showed curative effect at 20 mg/ 
kg against P. berghei in mice23. 
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8-quinoline quinones (XIIIb) were prepared and 
evaluated against P. berghei in mice, at 160-22 o NH-CH- ( C H  ) N/  'zH5 2 2 'c2ti5 
mg/kg. XIIIa (R= (C132)14CH3) was found to be 
an active cornpo~nd2~. 
R 
OH 
(XV) and their N-oxides were prepared and one 
such compound (R= cyclopentylamino, RI = H, IXIII b )  
, n=3) was found to have the highest chemothera- 
peutic coefficient. 
NH (CH ),.R 
A group of Russian w0rkers2~?o synthesised new w -  benzoquinoline derivatives and one of these deri- 
vatives; debaquine (XIV) has been proved to be R' 
antimalarial, even superior to chloroquin. Thus a ( X V )  
series of benzoquinolines. , 
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